Generex Biotechnology Corporation, the leader in drug delivery for metabolic diseases through the inner lining of the mouth, together with Benta s.a.l., the company's importation, marketing, distribution and sales sub-licensee in Lebanon, launched the commercial retail sales of Generex Oral-lyn in Lebanon.

The launch was announced at a press conference in Beirut with Lebanese minister of Health H E Muhammad Jawad Khalifah.

The product has been approved for importation and commercial marketing and sale in Lebanon by the Ministry of Public Health, and will be marketed and sold for the treatment of patients with type-1 and type-2 diabetes in Lebanon.

Generex Oral-lyn, Generex's proprietary oral insulin spray product, is the first non-injectable insulin approved in Lebanon. Generex Oral-lyn is delivered via the company's proprietary RapidMist device into the mouth. Unlike inhaled insulin products, buccally absorbed Generex Oral-lyn does not reach the lungs.

The launch of Generex Oral-lyn took place at Le Royal Hotel, Dbayeh. In addition to more than 150 endocrinologists and other healthcare providers in attendance, notable participants included Bernard Tannoury, chairman and CEO of Benta s.a.l, Bill Abajian, senior executive advisor, Global Licensing and Business Development, Generex Biotechnology Corporation, professor Paolo Pozzilli, head of the Department of Diabetes and Endocrinology, University Campus Bio-Medico, Rome, Italy, professor Sami Azar, The Department of Internal Medicine (Endocrinology), Faculty of Medicine, American University of Beirut-Medical Center, Beirut, Lebanon.

"It is with great enthusiasm that we launch Generex Oral-lyn in Lebanon alongside Benta s.a.l., known for their leading edge innovation," said Anna Gluskin, Generex's Chairman & Chief Executive Officer. "We anticipate that our truly innovative product will be well received and expand further into the Middle East over the coming year as we pursue our regulatory programme."

Generex is engaged in the research, development and commercialization of drug delivery systems and technologies.

Benta is a state-of-the-art manufacturing facility dedicated to the development of new and enhanced formulations of pharmaceutical products and production of a wide range of medical devices that fulfil most physician's needs.